Bristol Myers Squibb (BMY) Return on Equity [ROE] (2009 - 2026)
Bristol Myers Squibb's Return on Equity [ROE] was 43.72% in Q2 2026, up 14.72 percentage points from 29.00% a year earlier and up 6.06 percentage points from the prior quarter.
Powered by 
Analysis
Bristol Myers Squibb (BMY) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at Bristol Myers Squibb came in at 40.44%, up 79.38 percentage points from FY2024.
- Return on Equity [ROE] shows a five-year change of +60.52 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was -38.95% in FY2024 (-65.48 pp), 26.53% in FY2023 (+7.63 pp), 18.91% in FY2022 (-0.08 pp) and 18.99% in FY2021 (+39.07 pp).
- The Q2 2026 figure marks the highest quarterly Return on Equity [ROE] since Q4 2009.
- Compared with a year earlier, Return on Equity [ROE] has increased for six straight quarters, with an average year-over-year change of +20.47 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q4 2025 (a gain of 91.22 percentage points); the worst was Q4 2024 (a drop of 80.66 percentage points).
- Per Business Quant data, BMY's Return on Equity [ROE] in the three quarters before Q2 2026 was 37.67% (Q1 2026), 38.03% (Q4 2025) and 33.51% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | - |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 22.24% |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 43.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43.72% |
| Mar 31, 2026 | 37.67% |
| Dec 31, 2025 | 38.03% |
| Sep 30, 2025 | 33.51% |
| Jun 30, 2025 | 29.00% |
| Mar 31, 2025 | 32.14% |
| Dec 31, 2024 | -53.19% |
| Sep 30, 2024 | -42.29% |
| Jun 30, 2024 | -38.84% |
| Mar 31, 2024 | -26.65% |
| Dec 31, 2023 | 27.47% |
| Sep 30, 2023 | 27.18% |
| Jun 30, 2023 | 24.96% |
| Mar 31, 2023 | 23.27% |
| Dec 31, 2022 | 19.87% |
| Sep 30, 2022 | 20.47% |
| Jun 30, 2022 | 20.64% |
| Mar 31, 2022 | 18.53% |
| Dec 31, 2021 | 19.14% |
| Sep 30, 2021 | -14.52% |
API Access
Bristol Myers Squibb Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();